Valsartan benefits left ventricular structure and function in heart failure: Val-HeFT echocardiographic study
- 10 September 2002
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 40 (5) , 970-975
- https://doi.org/10.1016/s0735-1097(02)02063-6
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Antiremodeling effects on the left ventricle during beta-blockade with metoprolol in the treatment of chronic heart failureJournal of the American College of Cardiology, 2000
- Cardiac remodeling—concepts and clinical implications: a consensus paper from an international forum on cardiac remodelingJournal of the American College of Cardiology, 2000
- Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF)The Lancet, 1999
- Left Ventricular Remodeling With Carvedilol in Patients With Congestive Heart Failure Due to Ischemic Heart DiseasePublished by Elsevier ,1998
- The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart FailureNew England Journal of Medicine, 1996
- Effects of Carvedilol, a Vasodilator–β-Blocker, in Patients With Congestive Heart Failure Due to Ischemic Heart DiseaseCirculation, 1995
- Effects of Long-term Enalapril Therapy on Cardiac Structure and Function in Patients With Left Ventricular DysfunctionCirculation, 1995
- Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. SOLVD Investigators.Circulation, 1992
- A Comparison of Enalapril with Hydralazine–Isosorbide Dinitrate in the Treatment of Chronic Congestive Heart FailureNew England Journal of Medicine, 1991
- Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart FailureNew England Journal of Medicine, 1991